Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (481-490 of 721) with videos related to

Pageof 73
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2015
Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapyKen Herrmann, Christina Bluemel, Martina Weineisen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 8, 2019
Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric <sup>18</sup>F-FET PET-MRI and MR FingerprintingJohannes Haubold, Aydin Demircioglu, Marcel Gratz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 1, 2010
[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft modelBernd J Krause, Michael Souvatzoglou, Ken Herrmann, et al.
Nuklearmedizin. Nuclear Medicine|March 1, 2019
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus RecommendationLale Umutlu, Thomas Beyer, Johannes Stefan Grueneisen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 13, 2018
Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo)Onofrio A Catalano, Lale Umutlu, Niccolo Fuin, et al.
Annals of Nuclear Medicine|April 16, 2026
Semi-quantitative evaluation of early phase <sup>99m</sup>Tc-DPD scintigraphy in patients with suspected cardiac amyloidosisLukas Kessler, Leon Ferber, Christoph Rischpler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphomaKen Herrmann, Hinrich A Wieder, Andreas K Buck, et al.
Cancers|July 27, 2022
Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI-Clinically Relevant?Kai Jannusch, Nils Martin Bruckmann, Charlotte Johanna Geuting, et al.
European Urology Oncology|April 7, 2024
Validation of Prognostic and Predictive Models for Therapeutic Response in Patients Treated with [<sup>177</sup>Lu]Lu-PSMA-617 Versus Cabazitaxel for Metastatic Castration-resistant Prostate Cancer (TheraP): A Post Hoc Analysis from a Randomised, Open-label, Phase 2 TrialAndrei Gafita, Andrew J Martin, Louise Emmett, et al.
Molecular Imaging and Biology|October 12, 2010
Comparison of different SUV-based methods for response prediction to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRIKen Herrmann, Ralph A Bundschuh, Robert Rosenberg, et al.
Pageof 73

Showing results (481-490 of 721) with videos related to

Sort By:
Pageof 73
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2015
Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapyKen Herrmann, Christina Bluemel, Martina Weineisen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 8, 2019
Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric <sup>18</sup>F-FET PET-MRI and MR FingerprintingJohannes Haubold, Aydin Demircioglu, Marcel Gratz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 1, 2010
[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft modelBernd J Krause, Michael Souvatzoglou, Ken Herrmann, et al.
Nuklearmedizin. Nuclear Medicine|March 1, 2019
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus RecommendationLale Umutlu, Thomas Beyer, Johannes Stefan Grueneisen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 13, 2018
Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo)Onofrio A Catalano, Lale Umutlu, Niccolo Fuin, et al.
Annals of Nuclear Medicine|April 16, 2026
Semi-quantitative evaluation of early phase <sup>99m</sup>Tc-DPD scintigraphy in patients with suspected cardiac amyloidosisLukas Kessler, Leon Ferber, Christoph Rischpler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphomaKen Herrmann, Hinrich A Wieder, Andreas K Buck, et al.
Cancers|July 27, 2022
Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI-Clinically Relevant?Kai Jannusch, Nils Martin Bruckmann, Charlotte Johanna Geuting, et al.
European Urology Oncology|April 7, 2024
Validation of Prognostic and Predictive Models for Therapeutic Response in Patients Treated with [<sup>177</sup>Lu]Lu-PSMA-617 Versus Cabazitaxel for Metastatic Castration-resistant Prostate Cancer (TheraP): A Post Hoc Analysis from a Randomised, Open-label, Phase 2 TrialAndrei Gafita, Andrew J Martin, Louise Emmett, et al.
Molecular Imaging and Biology|October 12, 2010
Comparison of different SUV-based methods for response prediction to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRIKen Herrmann, Ralph A Bundschuh, Robert Rosenberg, et al.
Pageof 73